The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PureTech Health's share price is $29.92.
PureTech Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.03. Hence, PureTech Health's PS Ratio for today is 1,108.15.
Warning Sign:
PureTech Health PLC stock PS Ratio (=1187.5) is close to 10-year high of 1187.5
The historical rank and industry rank for PureTech Health's PS Ratio or its related term are showing as below:
PRTC'
s PS Ratio Range Over the Past 10 Years
Min: 26.4 Med: 117.39 Max: 1187.5
Current: 1187.5
During the past 12 years, PureTech Health's highest PS Ratio was 1187.50. The lowest was 26.40. And the median was 117.39.
PRTC's PS Ratio is ranked worse than 96.4% of 1000
companies
in the Biotechnology industry
Industry Median: 9.22
vs PRTC: 1187.50
PureTech Health PLC revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of PureTech Health was -66.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -54.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -42.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -8.40% per year.
During the past 12 years, PureTech Health's highest 3-Year average Revenue per Share Growth Rate was 119.00% per year. The lowest was -54.30% per year. And the median was -7.60% per year.
Back to Basics: PS Ratio
PureTech Health PS Ratio Historical Data
The historical data trend for PureTech Health's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PureTech Health's PS Ratio
For the Biotechnology subindustry, PureTech Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PureTech Health's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PureTech Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where PureTech Health's PS Ratio falls into.
PureTech Health PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PureTech Health's Share Price of today is $29.92.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. PureTech Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PureTech Health PS Ratio Related Terms
Thank you for viewing the detailed overview of PureTech Health's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
PureTech Health (PureTech Health) Business Description
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRTC has been successfully added to your 